June 24–26, 2027, Rome, Italy

Speaker

Andrey Belousov

ABAndrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University

Andrey Belousov

Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University

Ukraine

About Andrey Belousov

Andrey N. Belousov, MD, PhD, Professor - a Ukrainian medical scientist and pioneer in nanotechnology, who developed the world’s first biocompatible nanomedical drugs (Micromage-B, MCS-B, ICNB), officially registered and introduced into clinical practice since 1998. His work established a translational foundation for medical nanotechnology, linking fundamental biophysics with clinical applications in detoxification, hemocorrection, and neuroprotection. The published more 340 scientific works on results application of nanotechnology preparation in experimental and practical medicine. At now Andrey Belousov - the Head of Laboratory Applied Nanotechnologies, Professor of Kharkiv National Medical University, Ukraine.

Featured talk at Heart Congress 2027

“Magnetite nanoparticles (MCS-B) as a basis for antibacterial action: Mechanisms and clinical perspectives”

Background : Today the world’s attention is locked on the problem of bacterial resistant to antibiotics – one of the most serious threats to humanity. About 5.000 patients a year…

Read the full abstract →
View in scientific program →

1 Previous Presentation

Past editions

Join the Heart Congress 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us